Trials / Terminated
TerminatedNCT01515085
MRI-Guided Laser Induced Thermal Therapy
MRI-Guided Laser-Induced Thermal Therapy for Cytoreduction of Inoperable Grade III/IV GLiomas Prior to Chemotherapy and Radiation
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 1 (actual)
- Sponsor
- Rutgers, The State University of New Jersey · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Does MR-guided laser interstitial thermal therapy (MRgLITT) prior to chemotherapy and/or radiation give patients a beneficial increase in overall survival? Laser induced thermal therapy (LITT) is a minimally invasive procedure for destroying tissue through generation of heat.
Detailed description
Laser induced thermal therapy (LITT) is a procedure for destroying tissue through generation of heat. When used in conjunction with fiberoptic applicators, it offers an excellent means of minimally invasive surgery. As opposed to other thermal techniques like radio-frequency (RF) ablation, or cryo-ablation, LITT may be significantly faster and may exhibit sharper boundary of the thermal ablation zone. More importantly, LITT is highly compatible with MR imaging and when coupled with MR thermal imaging (MRTI) guidance, precise monitoring of the thermal ablation zone in order to avoid eloquent or critical structures is possible. In this study, we propose to evaluate MR-thermal image guided laser interstitial therapy for the treatment of inoperable brain tumors as upfront therapy prior to initiation of chemotherapy and radiation. MR-thermal imaging (MRTI) will be used to provide information on thermal dose delivered to the target and be used to control laser delivery to prevent damage to critical structures.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | laser interstitial thermal therapy | residual gliomas either after debulking or biopsy evaluated for intervention with laser ablation prior to onset of adjuvant therapy |
Timeline
- Start date
- 2011-08-01
- Primary completion
- 2012-06-01
- Completion
- 2012-06-01
- First posted
- 2012-01-23
- Last updated
- 2014-05-22
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01515085. Inclusion in this directory is not an endorsement.